Navigation Links
BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
Date:1/14/2009

ch statements are subject to a multitude of risks and uncertainties that could cause actual results, future circumstances, or events to differ materially from those projected in the forward-looking information. These risks include, but are not limited to, those associated with our capacity to finance our activities, the adequacy, timing, and results of our clinical trials, the regulatory approval process, competition, securing and maintaining corporate alliances, market acceptance of the Company's products, the availability of government and insurance reimbursements for the Company's products, the strength of intellectual property, the success of research and development programs, reliance on subcontractors and key personnel, and other risks and uncertainties detailed from time-to-time in our filings with the Canadian securities commissions.

Readers should not place undue reliance on the forward-looking information, given that (i) our actual results could differ materially from a conclusion, forecast or projection in the forward-looking information, and (ii) certain material factors or assumptions which were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information, could prove to be inaccurate. Additional information about (i) the material factors that could cause actual results to differ materially from the conclusion, forecast or projection in the forward-looking information, and (ii) the material factors or assumptions that were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information, is contained in the Company's annual report and other documents filed from time to time with the Canadian securities commissions which are available at www.sedar.com. These statements speak only as of the date they are made, and we assume no obligation to revise such statements as a result of any event, circumst
'/>"/>

SOURCE BioSyntech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
2. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
3. West Concludes Agreement with Nektar
4. Workforce Alliance Concludes Three-Year Biotech Training Program
5. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
6. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
8. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Center for Business Intelligence (CBI), a division ... the full agenda for the 6th ... The forum will take place at the ... Over 1,500 senior-level Finance, Accounting, Audit and ... since its inception, and this year,s meeting ...
(Date:12/15/2009)... the launch of several innovative new programs to aid ... current economic climate. The first is aimed at ... services over a period of 6, 12, 18, or ... companies. The second is aimed at more established ... 6 to 12 month period at discounted rates, and ...
(Date:12/14/2009)... State Biotech Leaders to Develop Blueprint to ... while Boosting Rhode Island,s Growing Biotech and ... Dec. 14 Several of Rhode ... and biotechnology gathered today at Brown University,s ... of medical innovation in Rhode Island and ...
(Date:12/14/2009)... -- Nektar Therapeutics (Nasdaq: NKTR ) announced ... serve on its board of directors. Winger ... 35 years of experience in corporate management, financial ... extensive industry perspective at an important time in ... and CEO of Nektar and member of the ...
Breaking Biology Technology:CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... Madison and Milwaukee, Wis. - By now, after ... it's pretty clear what chief executive officers want in ... projects on time and on budget, combined with an ... of each business unit, are among their demands. , ...
... - In 2000, so-called cleantech investments made up only one ... By late 2006, that slice of the venture capital pie ... markets are warming to technologies that produce alternative fuels, keep ... ,And while some environmentalists or policymakers may prefer to pick ...
... - Ken Rheingans' most immediate focus is next weekend's ... directly at BarCamp USA , the state's first national ... national BarCamp, which will be held August 23-26 on the ... Stratagem , said organizers would like to draw 5,000 ...
Other Biology Technology:What do CIOs want? Fusion2007 speakers weigh in 2What do CIOs want? Fusion2007 speakers weigh in 3Bio-energy and cleantech grab attention of investors 2Bio-energy and cleantech grab attention of investors 3Bio-energy and cleantech grab attention of investors 4Wisconsin to host technology BarCamp USA 2Wisconsin to host technology BarCamp USA 3
(Date:12/15/2009)... may have been grazing the North American steppe ... After plucking ancient DNA from frozen soil in ... techniques to uncover "genetic fossils" of both species ... and 10,500 calendar years. This new evidence suggests ... mammals endured longer in the continental interior, challenging ...
(Date:12/15/2009)... consumers can look forward to ultra-low powered or ... and mobile phones. This is made possible with ... are critical elements for power optimisation and higher ... Analog IC design is the key enabling capability ... the nation in advanced analog and mixed signal ...
(Date:12/14/2009)... researchers are part of an international team that has ... to revise the history of North America,s woolly mammoths ... A Earth and Atmospheric Sciences professor Duane Froese and ... radiocarbon dating of bones and teeth. That analysis concluded ... North America (the ,megafauna,) disappeared about 13,000 years ago. ...
Breaking Biology News(10 mins):Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Breast Abnormality Follow Up Often Later in Black Women 60080 1Breast Abnormality Follow Up Often Later in Black Women 60080 2Big Beefy Football Players May Face Heart Problems Later 60078 1Big Beefy Football Players May Face Heart Problems Later 60078 2Big Beefy Football Players May Face Heart Problems Later 60078 3Safety Management Services Inc Develops New Regional Preparation Course And Exam For CHEP Certification 60076 1Safety Management Services Inc Develops New Regional Preparation Course And Exam For CHEP Certification 60076 2Safety Management Services Inc Develops New Regional Preparation Course And Exam For CHEP Certification 60076 3
... the Foundation for Innovative New Diagnostics (FIND) have ... agreement to work in partnership for projects aimed ... in resource-poor and transitional countries. , "The ... on strengthening the foundation for infectious disease diagnosis ...
... New Zealand - Kiwifruit lovers can look forward to ... the release this week of crucial genetic data which ... varieties with increased health properties and exciting colours and ... HortResearch and listed New Zealand biotech company Genesis Research ...
... the eye and dispense medication accordingly could be ... biomedical engineers at UC Davis. , Tingrui Pan, ... Hailin Cong started with a material called polydimethylsiloxane ... silver on the PDMS in a precise pattern, ...
Other Biology News:ASM and FIND to partner on strengthening infectious disease diagnosis in developing nations 2Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3
...
... Nikon's Digital Sight DS-U2 camera controller is ... is specifically designed to interface any of the ... a PC computer through a USB2.0 interface. The ... complicated and cumbersome installation by equipping both hub ...
This unique buffer provides a gentle method for removal of primary and secondary antibodies to allow several reprobings on the same membrane. Gentle buffer will not alter the antigen for subsequent i...
...
Biology Products: